Biouniversa's Series B Round

Biouniversa raised a round of funding on January 01, 2013.

Biouniversa is focused on discovery and development of Diagnostic and Therapeutic Products based on Founders' discovery of the biological properties of the BAG3 protein on cell death regulation. BAG3 …

Articles about Biouniversa's Series B Round: